BioIntelliSense
GOLDEN, CO · Healthcare, Health Care · 102 employees
BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM). Our medical-grade Data-as-a-Service (DaaS) platform seamlessly captures multi-parameter vital signs, physiological biometrics, and symptomatic events through an effortless patient experience. The FDA-cleared, medical-grade BioButton® wearable device makes remo
Funding history
- Funding Round — $58.3M — Jun 2026
- Funding Round — $58.1M — Dec 2025
- Funding Round — $45.0M — Sep 2022
- Funding Round — $12.0M — Sep 2020
- Funding Round — $25.0M — Sep 2020
Recent signals
- Jun 04, 2026: Raised $58.3M
- Dec 19, 2025: Raised $58.1M
- Feb 17, 2025: BioIntelliSense Partners with Hicuity Health to Offer Scalable End-to-End Continuous Patient Monitoring
- Nov 25, 2024: Launched BioIntelliSense Launches BioButton® Wearable Device for Continuous Patient Monitoring to Enhance Early Detection of Deterioration.
- Oct 18, 2022: Acquired Biointellisense Acquires Alertwatch® Clinical Intelligence Engine To Expand Its Comprehensive Portfolio Of Continuous Patient Monitoring Solutions
- Sep 15, 2022: Raised $45.0M
- Sep 10, 2020: Raised $12.0M
- Sep 10, 2020: Raised $25.0M
See plans & pricing → Track BioIntelliSense’s funding, hiring, and signals — with verified contacts — on Fundz.